{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:06:17Z","timestamp":1789632377264,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Japan Institute for Health Security"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Staphylococcus-associated glomerulonephritis (SAGN) is a subtype of infection-related glomerulonephritis (IRGN) that often affects older adults and can progress rapidly. The role of immunosuppressive therapy in IRGN remains controversial due to the risk of worsening infection and limited evidence from randomized controlled trials. In this report, we present the case of a 70 year-old woman who developed bacteremia, pyogenic sacroiliitis, and multiple iliopsoas abscesses caused by methicillin-susceptible\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    . While receiving pathogen-directed antibiotics, the patient developed acute kidney injury (peak serum creatinine level, 5.48\u00a0mg\/dL) with gross hematuria and nephrotic-range proteinuria and subsequently required hemodialysis. Renal biopsy revealed endocapillary hypercellularity and cellular-to-fibrocellular crescents with mesangial expansion and hypercellularity. Immunofluorescence tests demonstrated IgA-dominant deposits with C3, and electron microscopy revealed mesangial-to-subendothelial electron-dense deposits, supporting the diagnosis of IgA-dominant SAGN. Glucocorticoid treatment was initiated after confirming regression of the iliopsoas abscesses and objective evidence of infection control, while continuing pathogen-directed antibiotics. Renal function gradually improved, and hemodialysis was discontinued. In patients with crescentic IgA-dominant SAGN with objectively confirmed infection control and progressive renal dysfunction despite adequate antimicrobial therapy, a carefully timed glucocorticoid treatment strategy, with continued antibiotic therapy and close monitoring, may lead to recovery of renal function and hemodialysis withdrawal.\n                  <\/jats:p>","DOI":"10.1007\/s13730-026-01182-7","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:50:44Z","timestamp":1789631444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful hemodialysis withdrawal with glucocorticoid treatment after achieving infection control in a case of crescentic IgA-dominant staphylococcus-associated glomerulonephritis"],"prefix":"10.1007","volume":"15","author":[{"given":"Yuto","family":"Nishiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimiko","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Omizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayuta","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-2644","authenticated-orcid":false,"given":"Daisuke","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"1182_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/ki.2012.407","volume":"83","author":"SH Nasr","year":"2013","unstructured":"Nasr SH, Radhakrishnan J, D\u2019Agati VD. Bacterial infection-related glomerulonephritis in adults. Kidney Int. 2013;83:792\u2013803.","journal-title":"Kidney Int"},{"key":"1182_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4132\/KoreanJPathol.2012.46.2.105","volume":"46","author":"TY Koo","year":"2012","unstructured":"Koo TY, Kim GH, Park MH. Clinicopathologic features of IgA-dominant postinfectious glomerulonephritis. Korean J Pathol. 2012;46:105\u201314.","journal-title":"Korean J Pathol"},{"key":"1182_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4103\/ijn.IJN_337_16","volume":"27","author":"J Dhanapriya","year":"2017","unstructured":"Dhanapriya J, Balasubramaniyan T, Maharajan SP, Dineshkumar T, Sakthirajan R, Gopalakrishnan N, et al. IgA-dominant infection-related glomerulonephritis in India: a single-center experience. Indian J Nephrol. 2017;27:435\u20139.","journal-title":"Indian J Nephrol"},{"key":"1182_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100:S1\u2013276.","journal-title":"Kidney Int"},{"key":"1182_CR5","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.ekir.2022.07.163","volume":"7","author":"S Arivazhagan","year":"2022","unstructured":"Arivazhagan S, Lamech TM, Myvizhiselvi M, Arumugam V, Alavudeen SS, Dakshinamoorthy S, et al. Efficacy of corticosteroids in infection-related glomerulonephritis-a randomized controlled trial. Kidney Int Rep. 2022;7:2160\u20135.","journal-title":"Kidney Int Rep"},{"key":"1182_CR6","doi-asserted-by":"publisher","first-page":"7482","DOI":"10.3390\/ijms23137482","volume":"23","author":"M Takayasu","year":"2022","unstructured":"Takayasu M, Hirayama K, Shimohata H, Kobayashi M, Koyama A. Staphylococcus aureus infection-related glomerulonephritis with dominant IgA deposition. Int J Mol Sci. 2022;23:7482.","journal-title":"Int J Mol Sci"},{"key":"1182_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/0971-4065.82141","volume":"21","author":"AS Kapadia","year":"2011","unstructured":"Kapadia AS, Panda M, Fogo AB. Postinfectious glomerulonephritis: is there a role for steroids? Indian J Nephrol. 2011;21:116\u20139.","journal-title":"Indian J Nephrol"},{"key":"1182_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.5414\/CNP70344","volume":"70","author":"S Okuyama","year":"2008","unstructured":"Okuyama S, Wakui H, Maki N, Kuroki J, Nishinari T, Asakura K, et al. Successful treatment of post-MRSA infection glomerulonephritis with steroid therapy. Clin Nephrol. 2008;70:344\u20137.","journal-title":"Clin Nephrol"},{"key":"1182_CR9","doi-asserted-by":"publisher","first-page":"e237011","DOI":"10.1136\/bcr-2020-237011","volume":"14","author":"RF Nogueira","year":"2021","unstructured":"Nogueira RF, Oliveira N, Sousa V, Alves R. Staphylococcus-induced glomerulonephritis: potential role for corticosteroids. BMJ Case Rep. 2021;14:e237011.","journal-title":"BMJ Case Rep"},{"key":"1182_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5152\/turkjnephrol.2022.21110","volume":"31","author":"H \u015eahin","year":"2022","unstructured":"\u015eahin H, Oguz EG, S\u00f6kmen FC, Selen T. Is Staphylococcus infection-associated glomerulonephritis overlooked? A case report and literature review. Turk J Nephrol. 2022;31:74\u20137.","journal-title":"Turk J Nephrol"},{"key":"1182_CR11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4103\/0971-4065.133051","volume":"24","author":"M Eswarappa","year":"2014","unstructured":"Eswarappa M, Ravi V, Mysorekar V, Gireesh MS. IgA dominant poststaphylococcal glomerulonephritis: complete recovery with steroid therapy. Indian J Nephrol. 2014;24:336\u20137.","journal-title":"Indian J Nephrol"},{"key":"1182_CR12","first-page":"e64769","volume":"16","author":"A Anantharaman","year":"2024","unstructured":"Anantharaman A, Pandurangan V, Srinivasan D, Joyce D, Balasubramanian S. The pulsing paradox: successful steroid therapy in infection-related glomerulonephritis. Cureus. 2024;16:e64769.","journal-title":"Cureus"},{"key":"1182_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12891-020-03446-4","volume":"21","author":"KS Ahn","year":"2020","unstructured":"Ahn KS, Kang CH, Hong SJ, et al. The correlation between follow-up MRI findings and laboratory results in pyogenic spondylodiscitis. BMC Musculoskelet Disord. 2020;21:428.","journal-title":"BMC Musculoskelet Disord"},{"key":"1182_CR14","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.3390\/jcm10122690","volume":"10","author":"S Hecquet","year":"2021","unstructured":"Hecquet S, Verhoeven F, Aubry S, Prati C, Wendling D, Chirouze C, et al. Interest of follow-up radiological imaging in patients with pyogenic vertebral osteomyelitis. J Clin Med. 2021;10:2690.","journal-title":"J Clin Med"},{"key":"1182_CR15","doi-asserted-by":"crossref","unstructured":"Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013; 41:580\u2013637.","DOI":"10.1097\/CCM.0b013e31827e83af"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-026-01182-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:50:49Z","timestamp":1789631449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-026-01182-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1182"],"URL":"https:\/\/doi.org\/10.1007\/s13730-026-01182-7","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors have declared no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was deemed to be outside the scope of the\n                      Ethical Guidelines for Medical and Biological Research Involving Human Subjects\n                      in Japan and was therefore judged by the Ethics Review Committee of the Japan Institute for Health Security to be exempt from ethical review.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient included in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"142"}}